163 related articles for article (PubMed ID: 37632052)
1. Polymorphisms Related to Iron Homeostasis Associate with Liver Disease in Chronic Hepatitis C.
Wróblewska A; Woziwodzka A; Rybicka M; Bielawski KP; Sikorska K
Viruses; 2023 Aug; 15(8):. PubMed ID: 37632052
[TBL] [Abstract][Full Text] [Related]
2. Analysis of polymorphism and hepatic expression of duodenal cytochrome b in chronic hepatitis C.
Rudnicka A; Woziwodzka A; Wróblewska A; Rybicka M; Bielawski KP; Sikorska K; Bernat A
J Gastroenterol Hepatol; 2017 Feb; 32(2):482-486. PubMed ID: 27439017
[TBL] [Abstract][Full Text] [Related]
3. Interferon lambda polymorphisms associate with body iron indices and hepatic expression of interferon-responsive long non-coding RNA in chronic hepatitis C.
Wróblewska A; Bernat A; Woziwodzka A; Markiewicz J; Romanowski T; Bielawski KP; Smiatacz T; Sikorska K
Clin Exp Med; 2017 May; 17(2):225-232. PubMed ID: 27125837
[TBL] [Abstract][Full Text] [Related]
4. IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Sato M; Kato N; Tateishi R; Muroyama R; Kowatari N; Li W; Goto K; Otsuka M; Shiina S; Yoshida H; Omata M; Koike K
J Gastroenterol; 2014 Apr; 49(4):748-54. PubMed ID: 23689989
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
Motawi TK; Shaker OG; Ismail MF; Sayed NH
Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
[TBL] [Abstract][Full Text] [Related]
6. Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients.
Jadid FZ; Chihab H; Alj HS; Elfihry R; Zaidane I; Tazi S; Badre W; Marchio A; El Filali KM; Tahiri M; Saile R; Pineau P; Ezzikouri S; Benjelloun S
Infect Genet Evol; 2018 Dec; 66():1-8. PubMed ID: 30172885
[TBL] [Abstract][Full Text] [Related]
7. IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients.
Khalil FO; Alsebaey A; Kasemy ZA; Abdelmageed SM; Bedair HM; Abdelsattar S
Expert Rev Anti Infect Ther; 2022 Jan; 20(1):121-129. PubMed ID: 34047252
[TBL] [Abstract][Full Text] [Related]
8. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in histone deacetylases improve the predictive value of IL-28B for chronic hepatitis C therapy.
López-Rodríguez R; Hernández-Bartolomé Á; Borque MJ; Rodríguez-Muñoz Y; Martín-Vílchez S; Trapero-Marugán M; García-Buey L; Muñoz de Rueda P; Rodrigo L; Vidal-Castiñeira JR; Salmerón J; Moreno-Otero R; Sanz-Cameno P
Genes Immun; 2013; 14(5):317-24. PubMed ID: 23615070
[TBL] [Abstract][Full Text] [Related]
10. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients.
Arafa M; Besheer T; El-Eraky AM; Abo El-Khair SM; Elsamanoudy AZ
Br J Biomed Sci; 2019 Apr; 76(2):64-69. PubMed ID: 31025604
[TBL] [Abstract][Full Text] [Related]
12. An intronic single nucleotide polymorphism in the MUTYH gene is associated with increased risk for HCV-induced hepatocellular carcinoma.
Sakurada A; Miyanishi K; Tanaka S; Sato M; Sakamoto H; Kawano Y; Takada K; Nakabeppu Y; Kobune M; Kato J
Free Radic Biol Med; 2018 Dec; 129():88-96. PubMed ID: 30218772
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-17 haplotyping predicts hepatocellular carcinoma in sofosbuvir, pegylated interferon-alpha-2a & ribavirin treated chronic hepatitis C patients.
Mostafa AM; Saafan HA; Al-Tawashi AS; Kasem MH; Alaa AM; Eltobgy MM; Moubarak AS; Gharib MM; Awwad MA; Omar HM; El-Derany MO
Virus Res; 2021 Jan; 292():198226. PubMed ID: 33171166
[TBL] [Abstract][Full Text] [Related]
14. Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia.
Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Khan MQ; Albenmousa A; Al-Ashgar HI; Khalaf NZ; Al-Ahdal MN; Al-Qahtani AA
BMC Infect Dis; 2014 Dec; 14():632. PubMed ID: 25551790
[TBL] [Abstract][Full Text] [Related]
15. TIM3 gene polymorphisms in patients with chronic hepatitis B virus infection: impact on disease susceptibility and hepatocellular carcinoma traits.
Li Z; Liu Z; Zhang G; Han Q; Li N; Zhu Q; Lv Y; Chen J; Xing F; Wang Y; Li F
Tissue Antigens; 2012 Aug; 80(2):151-7. PubMed ID: 22587604
[TBL] [Abstract][Full Text] [Related]
16. Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C.
Nanba S; Ikeda F; Baba N; Takaguchi K; Senoh T; Nagano T; Seki H; Takeuchi Y; Moritou Y; Yasunaka T; Ohnishi H; Miyake Y; Takaki A; Nouso K; Iwasaki Y; Yamamoto K
J Clin Pathol; 2016 Mar; 69(3):226-33. PubMed ID: 26290259
[TBL] [Abstract][Full Text] [Related]
17. Role of
Barooah P; Saikia S; Bharadwaj R; Sarmah P; Bhattacharyya M; Goswami B; Medhi S
Genet Test Mol Biomarkers; 2019 May; 23(5):325-331. PubMed ID: 30942619
[No Abstract] [Full Text] [Related]
18. Significance of Hereditary Hemochromatosis Gene (HFE) Mutations in Chronic Hepatitis C and Hepatocellular Carcinoma Patients in Egypt: A Pilot Study.
Dawood RM; Abd El Meguid M; Elrobe W; Salum GM; Zayed N; Mousa S; Medhat E
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2837-2845. PubMed ID: 34582652
[TBL] [Abstract][Full Text] [Related]
19.
Barooah P; Saikia S; Kalita MJ; Bharadwaj R; Sarmah P; Bhattacharyya M; Goswami B; Medhi S
Viral Immunol; 2020; 33(6):457-467. PubMed ID: 32352886
[TBL] [Abstract][Full Text] [Related]
20. Association of cytotoxic T-lymphocyte antigen-4 + 49A/G gene polymorphism with hepatocellular carcinoma risk in Chinese.
Wang C; Liu W; Zhao L; Dong Z
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1117-S1120. PubMed ID: 30539855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
